Net Cash Provided by (Used in) Operating Activities |
-61.3K |
USD |
+60.9% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Dec 31, 2022 |
Q4 2022 |
Net Cash Provided by (Used in) Investing Activities |
5.15K |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
91.4M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-61.9K |
USD |
+60.8% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
7.15M |
USD |
+31.3% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
7.15M |
USD |
+31.3% |
Dec 31, 2023 |
Q4 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-436K |
USD |
+65.3% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
6.94M |
USD |
+27.4% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
250M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
1.48M |
USD |
+3.65% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Share-based Payment Arrangement, Expense |
52.3K |
USD |
-82.2% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Sep 30, 2022 |
Q3 2022 |